UNITED STATES






UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K




CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report:  April 27, 2010

(Date of earliest event reported)





BIO-RAD LABORATORIES, INC.

(Exact name of registrant as specified in its charter)





Commission File Number: 1-7928


 

 

 

Delaware

 

94-1381833

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)



1000 Alfred Nobel Dr.

Hercules, California 94547

(Address of principal executive offices, including zip code)


(510) 724-7000

(Registrant’s telephone number, including area code)






Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))









 

ITEM 5.07

Submission of Matters to a Vote of Security Holders.


Bio-Rad Laboratories, Inc. (the “Company”) held its Annual Meeting of Stockholders on April 27, 2010.   The matters voted upon at the meeting and the results of those votes were as follows:


1. Election of Directors

 

 

 

 

 

 

 

Class of

 

 

 

 

 

Common Stock

Votes

Votes

Votes

Broker

 

to Elect

For

Withheld

Abstaining

Non-Votes

 

 

 

 

 

 

James J. Bennett

Class B

4,610,605

5,797

--

336,821

Louis Drapeau

Class A

17,280,630

916,340

--

2,322,329

Albert J. Hillman

Class A

17,088,755

1,108,215

--

2,322,329

Dr. Ted W. Love

Class B

4,607,228

9,174

--

336,821

Alice N. Schwartz

Class B

4,610,804

5,598

--

336,821

David Schwartz

Class B

4,610,605

5,797

--

336,821

Norman Schwartz

Class B

4,610,605

5,797

--

336,821

 

 

2. Ratification of the selection of Ernst & Young LLP as the Company’s independent auditors for the fiscal year ending December 31, 2010

 

Votes

Votes

Votes

Broker

For

Against

Abstaining

Non-Votes

6,994,471

8,380

2,301

       --

 

 

 

 












SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

 

 

 

 

 

 

 

 

 

 

 

 

BIO-RAD LABORATORIES, INC.

 

 

 

 

 

Date:

May 3, 2010

 

By:

/s/ Christine A. Tsingos

 

 

 

 

 

Christine A. Tsingos

 

 

 

 

 

Vice President, Chief Financial Officer